CKB activity measured in preoperative serum samples was higher in women with ovarian cancer (N = 45), compared to those with benign ovarian mass (9.6 U/L, N = 49) and healthy controls (8.5 U/L, N = 37), p = 0.0096 [27]. This evidence concerns the gene CKB and ovarian carcinoma.